| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.158 | 1.208 | 2.358 | 1.932 | 10.336 | 12.659 | 404 | 2.273 | 445 | 1.392 |
| Total Income - EUR | 13.158 | 1.208 | 2.358 | 1.932 | 10.336 | 12.659 | 404 | 2.273 | 445 | 1.392 |
| Total Expenses - EUR | 6.062 | 253 | 23 | 652 | 25 | 21 | 13 | 138 | 2.796 | 4.410 |
| Gross Profit/Loss - EUR | 7.096 | 955 | 2.334 | 1.281 | 10.310 | 12.638 | 392 | 2.135 | -2.351 | -3.018 |
| Net Profit/Loss - EUR | 6.701 | 919 | 2.264 | 1.223 | 10.000 | 12.297 | 380 | 2.074 | -2.351 | -3.018 |
| Employees | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pav Nutrimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 15.523 | 15.365 | 15.105 | 14.827 | 14.540 | 14.265 | 13.948 | 13.991 | 29.111 | 28.949 |
| Current Assets | 13.247 | 14.030 | 16.086 | 17.012 | 15.105 | 27.115 | 26.906 | 29.100 | 11.450 | 8.368 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 613 | 484 | 0 | 0 | 0 | 14.707 | 71 | 191 |
| Cash | 13.247 | 14.030 | 15.473 | 16.529 | 15.105 | 27.115 | 26.906 | 14.393 | 11.378 | 8.177 |
| Shareholders Funds | 28.770 | 29.395 | 31.161 | 31.812 | 29.645 | 41.380 | 40.842 | 43.042 | 40.561 | 37.316 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 0 | 0 | 29 | 28 | 0 | 0 | 12 | 49 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Pav Nutrimed Srl